Portfolio company
Univercells
Belgium · £25.5m raised
Raised
£25.5m
Latest stage
Series B
Rounds recorded
1
Backed by
1 investor
Sectors
About
This company provides biomanufacturing platforms and bioreactors to biotechnology firms and vaccine producers for the cost-effective production of biologics and gene therapies.
SourceFunding history · 1
Similar companies
Cellevate
This company develops nanofiber cell culture microcarriers for biopharmaceutical manufacturers to enhance viral vaccine and gene therapy production yields.
PBS Biotech
This company manufactures scalable bioreactor systems and single-use vessels for customers developing and producing commercial cell therapies.
Genezen
This company manufactures viral vectors for biotechnology and pharmaceutical firms developing cell and gene therapies.
Sensible Biotechnologies
This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.
Carroucell
This company manufactures flat microcarriers for cell culture in bioreactors for biopharmaceutical customers developing cell and gene therapies.
Cellares
This company provides automated manufacturing platforms and services for cell therapy development to biopharmaceutical organisations and academic research centres.
Forge Biologics
This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
